This is the trap that catches sonographers and cardiologists alike. A low gradient doesn’t always mean a mildly stenotic valve, and a small valve area doesn’t always mean severe stenosis.

The failing ventricle can’t generate enough force to tell you the truth.

In this lesson, you’ll learn exactly how to recognize low flow, low gradient AS with reduced ejection fraction, why the standard gradient cutoffs mislead you here, and how dobutamine stress echo separates the patients who need a new valve from the ones who need heart failure therapy instead.

Introduction

Low flow, low gradient (LFLG) aortic stenosis with reduced ejection fraction is one of the most consequential discordant patterns you’ll encounter in the echo lab. It occurs when left ventricular systolic dysfunction coexists with a small aortic valve area, but the stroke volume is too weak to generate the high velocities and gradients you’d expect from severe stenosis.

According to the 2017 EACVI/ASE focused update, LFLG AS with reduced EF is defined by four criteria occurring together: an effective aortic valve area (AVA) less than 1.0 cm², a mean transvalvular pressure gradient less than 40 mmHg, an LV ejection fraction less than 50%, and a stroke volume index (SVi) less than 35 mL/m².

Clinically, this matters because the gradient is flow-dependent. When the ventricle can’t push enough volume across the valve, velocity and gradient drop, even if the valve itself is critically narrowed. Left uninvestigated, a patient with true severe AS and a failing ventricle can be mislabeled as “moderate” and denied a valve replacement that could have reversed their heart failure.

Echo Evaluation

Step 1: Confirm the Discordance Is Real

Before reaching for dobutamine, rule out measurement error. This is where most discordant cases actually live.

• Recheck the LVOT diameter. Underestimating LVOT area is the single most common cause of a falsely low calculated AVA, since the diameter is squared in the continuity equation. Inner-edge to inner-edge in mid-systole about 0.5-1.0cm from the leaflet insertion points.

• Confirm the LVOT velocity was traced with a clean, laminar envelope and a well-defined peak, not a signal contaminated by flow convergence.

• Make sure the AS jet velocity was captured from multiple windows (apical, right parasternal, suprasternal) so you’re reporting the true maximum, not an underestimate from beam misalignment.

• Confirm the patient wasn’t hypertensive at the time of the study, since elevated afterload can suppress flow and blunt the gradient.

Step 2: Recognize the Pattern That Doesn’t Need a Stress Test

If a patient with reduced EF still has a resting AS velocity ≥ 4.0 m/s or a mean gradient ≥ 40 mmHg, this is not low gradient AS. The ventricle is mounting a normal response to a truly severe, high-afterload valve. Skip the dobutamine study.

Afterload vs. Preload

Preload is the volume/stretch on the ventricle at end-diastole (how much blood fills it before contraction), while afterload is the resistance/pressure the ventricle must overcome to eject blood during systole. Think of preload as “how full is the tank” and afterload as “how hard is the door to push open.”

Fun Fact

The LVOT isn't just elliptical, its shape actually changes as you move away from the annulus. In one study, 73% of patients had an "hourglass" LVOT (widest right at the annulus and progressively narrowing as you move deeper into the outflow tract — mean diameter dropped from 22.4 mm at the annulus to 20.2 mm just 10 mm below it).

The additional 22% were essentially cylindrical, and only 5% flared the opposite way, funnel-shaped and narrowest at the annulus (Guzetti et al, 2020).

Step 3: Dobutamine Stress Echocardiography (DSE)

When true LFLG AS is confirmed, low-dose DSE is the next step. The goal is to increase flow across the valve and watch how the valve responds.

Protocol basics:

• Start at a low dose, 2.5 or 5 mcg/kg/min, with stepwise increases every 3 to 5 minutes.

• Maximum dose is 10 to 20 mcg/kg/min. High doses should be avoided given the risk of arrhythmia, so continuous medical supervision is required.

• Record LVOT velocity, AS jet velocity, and biplane EF at every stage.

• Stop the infusion once you get a positive result, once heart rate rises more than 10 to 20 bpm above baseline or exceeds 100 bpm, or if symptoms, arrhythmia, or a blood pressure drop occur.

The clinical stakes here are real. True severe AS causing the LV dysfunction means aortic valve replacement can relieve afterload and allow ejection fraction to recover. Pseudosevere AS with LV dysfunction from another cause, like prior infarct or cardiomyopathy, generally does not benefit from valve replacement. Getting this distinction right changes the treatment plan entirely.

Common Mistakes to Avoid

• Diagnosing severe AS from valve area alone without checking whether flow and gradient are consistent.

• Skipping the LVOT diameter recheck before ordering a stress study.

• Using a high or rapidly escalating dobutamine dose in a low-dose contractile reserve protocol.

• Forgetting to track the dimensionless index across stages as a corroborating measure of AVA.

Key Takeaways

• LFLG AS with reduced EF: AVA < 1.0 cm², mean gradient < 40 mmHg, EF < 50%, and SVi < 35 mL/m².

• A low gradient in this setting can mean either true severe AS masked by a weak ventricle, or only moderate AS with a failing LV that can’t fully open the valve.

• Rule out measurement error first: LVOT diameter is the most common source of a falsely small AVA.

• A resting velocity ≥ 4.0 m/s or gradient ≥ 40 mmHg in a patient with reduced EF means the ventricle isn’t dysfunctional from AS alone; skip the stress study.

• Low-dose dobutamine stress echo distinguishes true severe from pseudosevere AS by tracking AVA, SV, and gradient changes as flow increases.

• The distinction changes management: true severe AS often improves with valve replacement, pseudosevere AS typically does not.

References

Baumgartner, Helmut, et al. “Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography.” Journal of the American Society of Echocardiography, vol. 30, no. 4, 2017, pp. 372-392, doi:10.1016/j.echo.2017.02.009.

Guzzetti, E., Capoulade, R., Tastet, L., Garcia, J., Le Ven, F., Arsenault, M., Bedard, E., Larose, E., Clavel, M.-A., & Pibarot, P. (2020). Estimation of stroke volume and aortic valve area in patients with aortic stenosis: A comparison of echocardiography versus cardiovascular magnetic resonance. Journal of the American Society of Echocardiography, 33(8), 953–963. https://doi.org/10.1016/j.echo.2020.03.020

This publication is for educational purposes only and does not constitute medical advice. By subscribing, you agree to our Terms of Use, Privacy Policy, and Disclaimer.

Perivalvular leak can look trivial at the valve level and reveal itself the moment you pan down into the LVOT.

Structural valve deterioration is no longer theoretical; the first TAVR patients are aging into it now.

In this article, you will learn how to evaluate a TAVR valve systematically, how to find and localize perivalvular leak, and what deteriorating transcatheter valve tissue looks like on echo.

Whether you are scanning immediately post-deployment or following a patient years out, the framework is the same. What changes is what you expect to find.

Read more

Here’s what you need to know.

Two Origins, One Obstructed Valve

Mitral stenosis isn’t a single disease. The two dominant forms — rheumatic and degenerative (calcific) — arise by completely different mechanisms and look completely different on echo.

Rheumatic MS follows episodes of acute rheumatic fever. The autoimmune response targets the leaflets and subvalvular apparatus, causing commissural fusion, chordal shortening, and scarring over years to decades. The result is the classic anterior leaflet “doming” or hockey stick deformity in the PLAX view, produced by commissural fusion restricting leaflet tip motion while the body remains relatively pliable. In PSAX at the leaflet tips, you’ll see the characteristic fish-mouth orifice.

Key findings to look for:

• Anterior leaflet doming in PLAX

• Posterior leaflet pulled anteriorly in diastole

• Subvalvular thickening and chordal fusion

• Fish-mouth orifice in PSAX at leaflet tips

• MVA reduction originating at the leaflet tips

Calcific MS is a completely different animal. It starts at the mitral annulus and extends inward toward the leaflet bases — not at the tips. The annulus becomes encased in calcium, reducing the effective orifice by restricting annular expansion and impeding leaflet motion from the base. There’s no doming. The leaflet tips may actually look relatively normal.

Key findings to look for:

• Dense, hyperechoic calcium at the annulus and posterior leaflet base

• Acoustic shadowing posterior to the calcium

• No leaflet doming

• No commissural fusion

• Calcium extending inward from annulus, not from leaflet tips

What They Share

Different origins, same hemodynamic consequences. Both forms produce:

• Left atrial enlargement

• Elevated mean transmitral gradient

• Reduced mitral valve area

• Pulmonary hypertension

• Susceptibility to atrial fibrillation

The Hemodynamics Worth Understanding

MS is a pre-LV lesion, which means LV systolic function is typically preserved or even hyperdynamic early on. If you see LV dysfunction in an MS patient, look for concurrent disease — it shouldn’t be from the MS itself.

MS is also heart-rate dependent. Faster rates shorten diastolic filling time and worsen the hemodynamic burden across the valve. Atrial fibrillation removes the atrial kick and raises average heart rate, which is why AF can precipitate acute decompensation in a patient who was previously compensated and stable.

Two things to document on every MS study, no exceptions: LAA thrombus (TEE preferred) and PASP from the TR jet. Elevated LA pressure creates the substrate for LAA thrombus formation. That same pressure transmits retrograde into the pulmonary circulation, and sustained pulmonary hypertension eventually leads to RV failure.

Key Takeaways

• Rheumatic MS: pathology starts at the leaflet tips. Look for anterior leaflet doming, commissural fusion, subvalvular scarring.

• Calcific MS: pathology starts at the annulus. No doming, no commissural fusion. Acoustic shadowing can limit your TTE assessment.

• Both cause LA enlargement, elevated gradients, reduced MVA, pulmonary hypertension, and AF.

• LV systolic function is typically preserved. LV dysfunction should prompt a search for concurrent disease.

• MS is heart-rate dependent. AF can tip a compensated patient into acute decompensation.

• Always document LAA and PASP on every MS study.

Here’s what you need to know…

What Is Qp:Qs and Why Does It Matter?

Qp:Qs is the ratio of pulmonary blood flow (Qp) to systemic blood flow (Qs). In a normal heart with no shunt, these values are equal — one unit of blood through the lungs for every one through the body. Qp:Qs = 1.0.

When a left-to-right shunt is present, extra blood recirculates through the lungs without delivering oxygen to the body. Qp rises, and the ratio climbs above 1.0. The higher the ratio, the greater the volume burden on the right heart and pulmonary vasculature.

If pulmonary hypertension develops and right-sided pressures begin to exceed left-sided pressures, the shunt reverses. Qp:Qs falls below 1.0. This is the hallmark of Eisenmenger syndrome — a point of no return where irreversible pulmonary vascular damage has occurred. Quantifying the shunt before this happens is exactly why this calculation matters.

How to Calculate It

Qp:Qs is calculated by comparing flow through the pulmonary and systemic circulations using the same principle as the continuity equation — flow equals cross-sectional area multiplied by velocity-time integral:

Four measurements, all from standard echo views. Because the diameter values are squared in the CSA calculation, errors are amplified in the final ratio. Precise 2D technique is non-negotiable.

How to Interpret the Number

• < 1.0: Reversed (right-to-left) shunting

• 1.0–1.4: Trivial, no hemodynamic significance

• 1.5–1.9: Hemodynamically significant, warrants cardiology referral

• ≥ 2.0: Substantial volume overload, typically warrants intervention

Always interpret alongside chamber size, pulmonary pressures, and clinical symptoms. The number informs the decision — it doesn’t make it.

Shunt-Specific Findings to Pair With It

ASD: Best assessed in the subcostal 4-chamber view, where the beam is perpendicular to the septum and dropout artifact is minimized. Don’t rely on the apical 4-chamber alone. Secondary signs of hemodynamic significance: RA and RV enlargement, septal flattening, elevated RVSP by TR jet.

VSD: Sweep through PSAX from apex to base with color Doppler to interrogate all septal segments. A high-velocity, turbulent jet is expected in small restrictive VSDs. A low-velocity VSD jet should prompt concern for elevated RV pressure. Volume overload pattern: LV and LA enlargement.

PDA: Best visualized in the high PSAX ductal view or suprasternal notch. Look for continuous color flow from the descending aorta into the MPA. A hallmark finding: retrograde diastolic flow in the descending thoracic aorta on PW Doppler — blood that should be going forward to the body is being stolen by the ductus. Volume overload pattern: LA and LV enlargement with dilated MPA.

Key Takeaways

• Color Doppler shows you a shunt exists. Qp:Qs tells you what it’s doing to the patient.

• Calculate it as (RVOT CSA × RVOT VTI) / (LVOT CSA × LVOT VTI) — four measurements from standard views.

• Thresholds: trivial below 1.5, hemodynamically significant at 1.5–1.9, intervention threshold at 2.0 and above.

• Diameter errors are amplified because values are squared. Measure carefully.

• Apply it to ASD, VSD, and PDA. Each has characteristic 2D and color findings — Qp:Qs quantifies the magnitude.

• Eisenmenger syndrome means the ratio has already flipped below 1.0. Catching the shunt before that point is the whole game.

In this lesson, you will learn the full hemodynamic story of the Valsalva maneuver, why the release phase is where the gradient lives, how to use PW to locate your obstruction before committing to CW, and the practical tricks that separate a clean, reportable gradient from a waveform you cannot measure.

The 6.88 m/s peak velocity in the case below did not come from luck. It came from setup.

Read more

We do now, and it’s almost never just a valve problem.

Roughly 1 in 100 of your patients was born with two aortic valve leaflets instead of three, and a meaningful share of them are carrying complications that have nothing to do with the valve itself, sitting in places most sonographers were never taught to look.

In this lesson, you’ll learn the four findings that travel with a bicuspid aortic valve far more often than chance allows, the views and measurements that catch each one, and the single finding most echo labs have never been taught to flag at all.

Introduction

A bicuspid aortic valve (BAV) forms when two of the three fetal valve cusps fail to separate during development, leaving the adult with two functional leaflets instead of three. It is the most common congenital heart defect in adults, affecting an estimated 0.5% to 2% of the general population, roughly 6.5 million people in the United States alone, and it occurs nearly three times more often in men than women.

The condition has a longer history than most people realize. Leonardo da Vinci is credited with the earliest known sketch of a bicuspid valve, drawn around 1513 as part of his anatomical studies. By the time Sir William Osler ran one of the first systematic autopsy reviews in 1886, he had already documented the valve in just over 1% of consecutive cases, early evidence that this has never been a rare curiosity, only an underrecognized one.

Read more

Then you see it: a mobile linear structure in the left atrium, billowing with each heartbeat, separating the chamber into two distinct compartments.

Left atrial dissection. One of the rarest complications in cardiac surgery, and you’…

Read more

The MR jet looks smaller, but your usual grading tools no longer apply.

Whether you have seen this before or not, the question is the same: do you know how to evaluate it?

This article follows a real patient with a flail P1 segment of the posterior mitral valve leaflet through the full TEER pathway: pre-procedure TTE, peri-procedure TEE, and post-procedure TTE. It picks up where our mitral regurgitation series leaves off. If you haven’t read those yet, start here:

• The Why Before the What: Mitral Valve Anatomy Built From the Ground Up

• Types of Mitral Regurgitation: Vena Contracta Explained

• Quantifying MR: The Stroke Volume Method

• Mitral Regurgitation: PISA, Vena Contracta, Grading & Clinical Pearls

If you have, you’re ready for what comes next.

Read more

In the midst of three-dimensional imaging and the introduction of global longitudinal strain to standard transthoracic protocols, we forget to revisit the basics.

A Brief History

Echocardiography was born when cardiologist Dr. Inge Edler teamed up with biophysicist Dr. Carl Hellmuth Hertz to test sonar technology on humans. Their goal was to make quantitative analysis of mitral stenosis and mitral regurgitation by non-invasive means.

Edler and Hertz first had to overcome a widespread belief that ultrasound waves could not detect the subtle difference between heart muscle and blood. The key was finding the right frequency: one powerful enough to penetrate tissue but precise enough to produce clear images. Hertz landed on 2.5 MHz, and early tests on excised hearts confirmed that the boundary between muscle and fluid could indeed be detected.

Their initial images, called A-mode, were limited to showing only the distance between the transducer and a structure. To capture how cardiac structures moved over time, Edler invented what we now call M-mode.

He recorded the output by running film past an oscilloscope at a constant speed. Stationary structures appeared as straight lines on the film, while moving structures traced wave-like patterns that mirrored their actual motion.

Normal M-Mode of the Mitral Valve

The mitral valve M-mode trace is defined by five key deflection points. Each reflects a distinct moment in the cardiac cycle.

D Point: Marks the onset of diastole and the initial opening of the mitral valve.

E Point: Represents the point of maximal opening of the mitral leaflet during the early, rapid ventricular filling phase.

F Point: The most posterior (closed) position of the leaflet immediately following the initial rapid filling wave, as pressures between the left atrium and left ventricle equalize.

A Point: Reflects the brief re-opening of the mitral valve caused by the “atrial kick” (active atrial contraction).

C Point: Marks the complete, final closure of the mitral valve leaflets right at the beginning of ventricular systole.

Mitral Stenosis M-Mode

In mitral stenosis, the valve is stiff and obstructed, so the normal pressure gradients that drive leaflet motion are blunted. Here’s how each point is affected:

D Point: delayed and reduced opening, because the stiff valve resists early diastolic filling.

E Point: reduced amplitude, because the valve can’t open fully; the E point is lower than normal.

E-F Slope: this is the classic finding; normally the valve drifts closed between E and F as pressures equalize, but in MS the LA pressure stays elevated, so the leaflet barely drifts at all, producing the hallmark flat or near-flat E-F slope.

F Point: less posterior than normal (the valve never really closes between E and A) because the persistent LA-LV gradient keeps the leaflet pushed open.

A Point: reduced or absent; atrial contraction contributes less additional opening when the valve is already being held open by an elevated gradient (and in advanced MS with atrial fibrillation, the A point disappears entirely).

C Point: closure is delayed compared to normal, reflecting the prolonged pressure half-time; the valve stays open longer before systole finally forces it shut.

According to the International Journal of Cardiology, atrial fibrillation develops in up to 40% of patients with mitral stenosis as chronic left atrial pressure overload remodels the atrium, erasing the A point on M-mode and eliminating the atrial kick the stenotic valve depends on.

The Temporal Resolution Advantage

M-mode samples a single line of interrogation at approximately 1,000 frames per second, compared to 30-80 frames per second for standard 2D imaging. That roughly 10-20x improvement in temporal resolution is why M-mode still earns its place in a modern echo lab.

Pathological Patterns to Recognize

• Calcification brightens the trace. Calcified leaflets appear as dense, bright echoes on M-mode. In calcific mitral stenosis, the AML and PML may move in concert (both anteriorly) rather than in opposite directions, and the leaflet echoes are notably thickened and hyperreflective.

• Mitral valve prolapse: watch the C-D segment. In MVP, the AML (or both leaflets) dips posteriorly between the C and D points, creating a characteristic mid-to-late systolic sag. This posterior displacement during systole is the M-mode hallmark of prolapse.

• Aortic regurgitation: anterior leaflet flutter. High-frequency, fine oscillations of the AML during diastole are caused by the AR jet striking the leaflet. This is best seen on M-mode and may be the first clue that AR is present. It also underlies the Austin Flint murmur.

• Vegetations: independent leaflet motion. A mass attached to a valve leaflet that oscillates independently, at a different frequency or amplitude, suggests a vegetation. M-mode captures this with a fidelity that 2D imaging cannot match.

• Intimal flaps in aortic dissection. In the PLAX view, an intimal flap in the aortic root may appear as a linear echo moving independently within the aorta. M-mode through the aortic root confirms the oscillating motion pattern.

Key Takeaways

• M-mode was invented to evaluate the mitral valve and remains one of the most informative techniques in the echo lab.

• The E-F slope is the classic M-mode finding in mitral stenosis: a flat slope means the LA pressure stays elevated throughout diastole, preventing normal leaflet drift.

• Anterior motion of the posterior mitral leaflet in diastole is the pathognomonic M-mode sign of rheumatic mitral stenosis.

• A point disappears in atrial fibrillation, eliminating the atrial kick contribution to filling.

• High temporal resolution (~1,000 fps) gives M-mode a diagnostic edge for vegetations, intimal flaps, AR-induced leaflet flutter, and MVP sagging that 2D imaging routinely misses.

• Always interpret M-mode in the context of 2D, Doppler, and clinical findings. No single modality tells the whole story.

References

Edler I, Hertz CH. The use of ultrasonic reflectoscope for the continuous recording of the movements of heart walls. 1954. Clin Physiol Funct Imaging. 2004;24(3):118-136. doi:10.1111/j.1475-0961.2004.00538.x

Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease. J Am Coll Cardiol. 2014;63(22):e57-e185. doi:10.1016/j.jacc.2014.02.536

Wann LS, Weyman AE, Feigenbaum H, Dillon JC, Johnston KW, Eggleton RC. Determination of mitral valve area by cross-sectional echocardiography. Ann Intern Med. 1978;88(3):337-341. doi:10.7326/0003-4819-88-3-337

Sagie A, Freitas N, Padial LR, et al. Doppler echocardiographic assessment of long-term progression of mitral stenosis in 103 patients: valve area and right heart disease. J Am Coll Cardiol. 1996;28(2):472-479. doi:10.1016/0735-1097(96)00141-3

Hatle L, Angelsen B, Tromsdal A. Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound. Circulation. 1979;60(5):1096-1104. doi:10.1161/01.CIR.60.5.1096

Most sonographers can spot a thickened mitral valve. Far fewer can confidently measure and grade severity, explain why those changes are happening, or know exactly which measurements are most reliable.

In this lesson, you’ll learn what causes each form of mitral stenosis, how to distinguish them on echo, what findings they share, and the exact measurements, grading thresholds, and hemodynamic consequences that make this valve one of the most important structures you scan.

Studying for your adult echocardiography board exam? Click here for free study tools.

Introduction

Mitral stenosis (MS) is a mechanical obstruction of the mitral valve that impedes blood flow from the left atrium (LA) into the left ventricle (LV) during diastole. Rather than opening freely to a normal area of 4.0-6.0 cm², a stenotic mitral valve forces the heart to generate an abnormal pressure gradient just to fill the left ventricle. The result is a progressive, hemodynamic burden that ultimately remodels the left atrium, increases pulmonary pressures, and can lead to right heart failure, atrial fibrillation, and stroke.

Worldwide, mitral stenosis remains a significant cause of cardiovascular morbidity and mortality. According to the American Heart Association, rheumatic heart disease accounts for the vast majority of MS cases globally, disproportionately affecting low- and middle-income countries where rheumatic fever remains endemic. In higher-income countries, degenerative (calcific) mitral stenosis is increasingly recognized as a distinct and growing entity, particularly in older adults with heavy mitral annular calcification (MAC).

Clinically, patients with significant MS may present with exertional dyspnea, fatigue, orthopnea, or frank pulmonary edema. Atrial fibrillation is a common complication, often accelerating symptom onset due to the loss of atrial kick and a reduced diastolic filling period. In advanced disease, symptoms of right heart failure dominate. Echocardiography is the primary tool for diagnosis, etiology assessment, severity grading, and procedural planning in mitral stenosis.

Echo Evaluation

Two Origins, One Obstructed Valve

Mitral stenosis is not a single disease. The two dominant forms, rheumatic and degenerative (calcific), arise by completely different mechanisms and produce different structural abnormalities on echo. Recognizing which type you’re looking at shapes the entire clinical and management picture.

Rheumatic Mitral Stenosis

Rheumatic MS follows episodes of acute rheumatic fever, typically occurring in childhood or early adulthood, caused by an autoimmune response to group A streptococcal pharyngitis. The inflammatory process targets the mitral valve leaflets and subvalvular apparatus. Over years to decades, the leaflets thicken, fuse at the commissures, and the chordae tendineae shorten and scar. The result is a characteristic “doming” or “hockey stick” deformity of the anterior mitral leaflet in the parasternal long-axis (PLAX) view, produced by commissural fusion restricting leaflet tip motion while the body of the leaflet remains relatively pliable.

Read more

You are seeing what happens when three conditions converge: stasis, endothelial injury, and hypercoagulability.

Virchow’s triad is the mechanism behind every clot your probe will ever find. Understanding it changes how you interpret what you see.

The Framework

Rudolf Virchow described the conditions that promote thrombosis in the 19th century. The three elements are:

• Blood stasis: sluggish or turbulent flow that allows clot to organize

• Endothelial injury: disruption of the inner wall surface, triggering coagulation

• Hypercoagulability: a systemic shift toward clot formation driven by inflammation, genetics, or pathology

All three elements leave echo-detectable signatures. The findings on your screen are downstream consequences of this triad playing out in real time.

Where You See It in the Echo Lab

Left Ventricular Thrombus

LVT is the most mechanistically straightforward example. An anterior MI injures the endocardium at the apex. Akinesis or dyskinesis creates a hemodynamic backwater where flow stalls. Post-infarct inflammation drives a hypercoagulable state. All three arms of the triad converge at the same anatomic site.

On echo: look for the wall motion abnormality that explains the stasis, then assess the apex carefully. Contrast enhancement is the most reliable tool for confirmation. Thrombus does not enhance. Trabeculation does.

Left Atrial Thrombus

The left atrium is the most common site for cardiac thrombus formation, and the LAA accounts for roughly 90% of cases in nonvalvular AF. The mechanism is straightforward: AF eliminates coordinated atrial contraction, stasis develops in the appendage, and chronic atrial distension injures the endothelium over time. All three arms of the triad are present.

TTE cannot reliably exclude LAA thrombus. TEE is the standard of care. Spontaneous echo contrast, the swirling smoke-like appearance from erythrocyte aggregation in low-flow states, is a precursor finding and belongs in your report. A ball thrombus, a free-floating LA mass most often seen with rheumatic mitral stenosis and a severely dilated atrium, sits at the high-mobility extreme of this spectrum. When you find one, escalate immediately.

Right Heart Thrombus and PE

In pulmonary embolism, Virchow’s triad plays out upstream in the deep venous system. The echo findings are the right heart’s response to the resulting obstruction: RV pressure overload, septal flattening, and elevated TR velocity. Occasionally you will catch the clot itself in transit through the right heart, a finding that demands urgent escalation.

The right heart findings do not tell you where the clot formed. They tell you what the heart is doing because of it. That distinction is the whole point of the framework.

Why the Mechanism Matters

Pattern recognition will get you to the finding. Understanding Virchow’s triad gets you to the clinical picture.

When you see an apical thrombus, you know endothelial injury occurred there. You look for the wall motion abnormality driving the stasis. You recognize that the patient is likely in a prothrombotic state beyond that single segment.

When you see spontaneous echo contrast in the LAA, you are watching stasis in progress before the thrombus has even formed. That finding belongs in your report.

When you see a right heart in pressure overload, you understand what is driving it and what the clinical team needs from you.

Virchow’s triad is not abstract physiology. Every finding on your screen has a mechanism. Knowing it makes you a more precise interpreter of what you see.

Key Takeaways

• Virchow’s triad describes three conditions that promote thrombosis: stasis, endothelial injury, and hypercoagulability. All three produce echo-detectable findings.

• LVT forms at the intersection of all three: infarcted endocardium, akinetic apex, and post-MI inflammation. Contrast echo is the most reliable confirmation tool.

• LA and LAA thrombus is driven primarily by stasis from AF. TEE is required for reliable exclusion. Spontaneous echo contrast is a precursor finding and belongs in your report.

• Ball thrombus is a high-mobility LAA or LA thrombus variant most often associated with rheumatic MS and AF. Its mobility makes it particularly high risk.

• In PE, echo detects the right heart’s response to upstream clot, not the clot’s origin. RV dilation, septal flattening, and elevated TR velocity are the downstream signatures.

• Understanding the mechanism behind the finding makes you a more precise interpreter. You are reading a thrombotic process, not just describing anatomy.

In this article, you will see a massive, multilobed, mobile left ventricular thrombus through both lenses: a contrast-enhanced TTE that raised the alarm, and a 3D TEE that revealed the full anatomy. Along the way, you will learn how to identify, characterize, and report LV thrombus, and when pushing further with advanced imaging is not optional.

Read more

You’ve visualized the aortic valve. Reduced area. Calcified. Maybe severely so. But the gradient? It’s barely in the moderate range…and nothing adds up.

This is one of the most clinically consequential discrepancies in all of echocardiography, and it affects more patients than you might think. Miss it, and a patient …

Read more

Apical sparing on strain doesn’t always mean amyloidosis — and assuming it does could lead you to the wrong diagnosis entirely. In fact, one of the most deceptive presentations in all of echo is the severely hypertrophic heart that looks like infiltrative disease but isn’t. The key is knowing exactly where to look beyond the strain bull’s-eye plot.

In this lesson, you’ll learn how to systematically distinguish hypertrophic cardiomyopathy from cardiac amyloidosis using a layered, multiparametric approach — including why myocardial work analysis changes the game when GLS alone misleads you on echocardiography.

This case comes to us from Dr. Antonio Agić at the Magdalena Clinic for Cardiovascular Disease in Croatia — exactly the kind of global collaboration that makes The Echo Journal what it is. Want to contribute a case or topic? Send us a message.

Read more

In this lesson, you’ll l…

Read more

Most echo education focuses on follow-up. Almost none of it covers what happens the day of the procedure. Your images before, during, and immediately after deployment directly affect whether complications get caught in time.

In this article, you will learn what echocardiography does on TAVR procedure day: the pre-procedural baseline study, your role in the lab during valve deployment, and the rapid structured assessment you run the moment the valve is seated.

Read more

Read more

Two patients. Both have HCM. Both have walls that are thick. But one is about to have a lethal arrhythmia, and the other probably isn’t.

Apical HCM and mid-ventricular obstructive HCM (MVOHCM) are not the same diagnosis, even though they’re separated by only a few centimeters of myocardium.

Miss the difference on echo and you can completely change a patient's treatment plan.

In this lesson, you’ll learn how to distinguish apical HCM from mid-ventricular obstructive HCM using 2D echo and Doppler — including the exact views and measurements that separate them, the associated findings that should change your clinical impression immediately, and why one variant carries a significantly heavier arrhythmic burden than the other. By the end, you’ll have a framework you can apply on your very next study.

Introduction

Hypertrophic cardiomyopathy (HCM) is defined as unexplained left ventricular wall thickening ≥ 15 mm in the absence of another cardiac or systemic disease. HCM is one of the most genetically heterogeneous cardiovascular disorders we encounter.

Classic HCM is the one everyone teaches. But the two variants most likely to be misdiagnosed, and change a patient's management, are apical HCM and MVOHCM.

Classic HCM is the one everyone teaches. But the two variants most likely to be misdiagnosed are apical HCM and MVOHCM. In this week's full lesson: the 2D findings that make or break the diagnosis, the Doppler patterns that separate these two variants when the walls look deceptively similar, and what current research is telling us.

Studying for Adult Echo Boards? [Click Here]

Read more

One is surgically curable. The other is not.

Getting this wrong changes the outcome.

These two conditions sit at one of the hardest diagnostic crossroads in echocardiography. Here are the pivot points that separate them when everything else looks the same.

A few weeks ago we covered constrictive pericarditis step by step, and earlier this week we broke down restrictive cardiomyopathy in detail. If you haven’t read those yet, start there. The findings below will make a lot more sense with that foundation.

Why This Matters

The echo findings in CP and RCM overlap significantly. Both present with preserved ejection fraction, diastolic dysfunction, biatrial enlargement, and signs of right heart failure. But constrictive pericarditis is potentially curable with pericardiectomy, the surgical removal of the pericardium. Restrictive cardiomyopathy is not. In advanced cases, transplant is the only option. This distinction has to be made correctly.

The Pivot Points

1. Tissue Doppler: Start Here

This is your most reliable separator.

In RCM, the myocardium is stiff and longitudinal function suffers. The early diastolic mitral annular velocity (e’), a tissue Doppler measurement of annular motion, is reduced.

In CP, the muscle is often relatively preserved. The annulus hypermoves to compensate for constrained filling. Per ASE guidelines, a medial mitral annular e’ of 8 cm/s or greater in a heart failure patient should immediately raise suspicion for CP. This is called annulus paradoxus: a preserved or elevated e’ where you would expect it to be low.

The second clue is annulus reversus. Normally, lateral e’ exceeds medial e’. In CP, the fibrotic pericardium tethers the lateral wall and blunts its motion, so medial e’ equals or exceeds lateral e’. This reversal is present in up to 75% of surgically proven CP cases. It does not occur in RCM.

When medial e’ is higher than lateral e’, the pericardium is the most likely culprit. That pattern does not happen in myocardial disease.

2. Respiratory Variation

In CP, the rigid pericardium creates exaggerated ventricular interdependence. When LV filling drops with inspiration, RV filling surges to compensate. The Doppler signature is specific: mitral E-wave velocity drops more than 25% with the first beat of inspiration, while tricuspid E-wave velocity increases more than 40%. That reciprocal seesaw is CP until proven otherwise.

In RCM, the pericardium is normal. Filling pressures are elevated equally across the respiratory cycle. Respiratory variation is absent or minimal.

One caveat: markedly elevated left atrial pressure can blunt this pattern in CP. If you suspect CP but are not seeing variation, reducing preload with a head-up tilt can unmask it. This has no effect in RCM.

3. Strain Pattern

GLS is reduced in both conditions, so the number alone does not help you. The pattern does. In RCM from infiltrative disease, particularly amyloidosis, longitudinal strain is significantly impaired, and you may see the characteristic apical sparing pattern. In CP, circumferential strain tends to be more affected than longitudinal strain. If the strain map looks like amyloid, RCM moves to the top of the list.

4. Pericardial Findings

If you can see pericardial abnormalities, they point toward CP. Look for a bright or thickened pericardium on 2D, loss of pericardial slide at the RV free wall, and a railroad track sign on M-mode. In RCM, the pericardium is normal.

A normal-appearing pericardium on echo does not rule out CP. CT and MRI are the gold standard for confirming pericardial thickness when the diagnosis is uncertain.

Constrictive Pericarditis vs Restrictive Cardiomyopathy

Key Takeaways

• Tissue Doppler is your most reliable separator. A medial e’ of 8 cm/s or greater in a heart failure patient points toward CP.

• Annulus reversus, where medial e’ equals or exceeds lateral e’, is present in up to 75% of surgically proven CP cases and does not occur in RCM.

• Respiratory variation is the other key pivot. Mitral E-wave drop greater than 25% with inspiration and a reciprocal tricuspid rise greater than 40% support CP. Absent variation favors RCM.

• Strain patterns differ: apical sparing and longitudinal impairment favor RCM, circumferential impairment favors CP.

• Do not use E/e’ to estimate filling pressures in CP. Annulus paradoxus makes it unreliable.

References

Brandt, Roland R, and Jae K Oh. “Constrictive Pericarditis: Role of Echocardiography and Magnetic Resonance Imaging.” Escardio, 11 Nov. 2025, www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-15/Constrictive-pericarditis-role-of-echocardiography-and-magnetic-resonance-imaging.

Garcia, Mario J. “Constrictive pericarditis versus restrictive cardiomyopathy?” Journal of the American College of Cardiology, vol. 67, no. 17, May 2016, pp. 2061–2076, https://doi.org/10.1016/j.jacc.2016.01.076.

Gerig, Don. “Constrictive Pericarditis vs Restrictive Cardiomyopathy - Echo Findings That Truly Differentiate.” Cardioserv, 6 Jan. 2026, www.cardioserv.net/constrictive-pericarditis-vs-restrictive-cardiomyopathy-echo-findings/.

Hatle, L K, et al. “Differentiation of constrictive pericarditis and restrictive cardiomyopathy by Doppler echocardiography.” Circulation, vol. 79, no. 2, Feb. 1989, pp. 357–370, https://doi.org/10.1161/01.cir.79.2.357.

Nagueh, Sherif F., Danita Y. Sanborn, et al. “Recommendations for the evaluation of left ventricular diastolic function by echocardiography and for heart failure with preserved ejection fraction diagnosis: An update from the American Society of Echocardiography.” Journal of the American Society of Echocardiography, vol. 38, no. 7, July 2025, pp. 537–569, https://doi.org/10.1016/j.echo.2025.03.011.

Nagueh, Sherif F., Otto A. Smiseth, et al. “Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of cardiovascular imaging.” Journal of the American Society of Echocardiography, vol. 29, no. 4, Apr. 2016, pp. 277–314, https://doi.org/10.1016/j.echo.2016.01.011.

“Restrictive Cardiomyopathy.” Www.Heart.Org, 29 May 2024, www.heart.org/en/health-topics/cardiomyopathy/what-is-cardiomyopathy-in-adults/restrictive-cardiomyopathy.

This publication is for educational purposes only and does not constitute medical advice. By subscribing, you agree to our Terms of Use, Privacy Policy, and Disclaimer.

Restrictive cardiomyopathy is one of the few conditions that can devastate cardiac function while looking almost unremarkable on a casual read.

In this article, you will learn the 4 echo steps to recognize restrictive cardiomyopathy:

1. The diastolic pattern that gives it away

2. The 2D findings most sonographers underreport

3. Where strain imaging adds value

4. The right heart clues that confirm what everything else is suggesting

Read more